FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading

Infant Deaths Trigger Recall of Fisher-Price Soothers, Gliders Hundreds of thousands of Fisher-Price 4-in-1 Rock ‘n Glide Soothers and 2-in-1 Soothe ‘n Play Gliders sold in the United States and Canada have been recalled after four U.S. infants died of suffocation. The deaths occurred in the 4-in-1 Rock ‘n GlideContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — Patients with advanced prostate cancers may have newfound hope: Researchers identified a new potential treatment for men with metastatic castration-resistant prostate cancer, which has no cure. Metastatic castration-resistant prostate cancer means the disease continues to spread despite therapies that deplete male hormones (androgens)Continue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading